课题基金 / 基金详情

PROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS)

PROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS)
前列腺癌、肺癌、结肠直肠癌、卵巢癌 (PLCO) 病因学和早期标志物研究 (EEMS)
批准号:
10862524
负责人:
THOMAS RILEY
金额:
$115.31万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-07-20 至 2024-07-19

项目摘要

项目成果

THOMAS RILEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Etiologic and Early Marker Studies (EEMS) is a component of the Prostate Lung Colorectal and Ovarian (PLCO) Trial. By collecting biologic materials and risk factor information from participants, PLCO EEMS provides a rich resource for research on cancer etiology and early detection biomarkers. The PLCO Biorepository stores approximately 2.9 million biologic specimens collected from PLCO participants. These specimens and their associated data are available to all qualified researchers through an application and peer-review process. EEMS also covers tissue specimens from the LSS component of the National Lung Screening Trial (NLST).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS)
INFORMATION TECHNOLOGY AND INFORMATICS SUPPORT TO THE DIVISION OF CANCER PREVENTION.
INFORMATION TECHNOLOGY AND INFORMATICS SUPPORT TO THE DIVISION OF CANCER PREVENTION.
SUPPORT SERVICES FOR THE PLCO ETIOLOGIC&EARLY MARKER STUDIES (PLCO EEMS)
海外基金